Join Talking Laboratories & Howard McLeod, Pharm D & Exec. Clinical Director of Precision Health at Intermountain Healthcare, on July 12th at 12:00 EDT to discuss the strategy of using precision medicine to predict and prevent health conditions using population health tactics.
Join Talking Labs and the PMI Institute, featuring David Johnson from 4sight Health. David will be discussing how precision medicine starts with precision wellness and there are cataclysmic changes occurring in precision medicine that will lead to BIG changes in healthcare.
Join Talking Laboratories. and the Precision Medicine Institute for episode 34 with Lisa Jean, COO, and Chief Strategy Officer at Gestalt Diagnostics on Thursday, June 2nd at 12:00 pm EDT. We are excited to host Lisa-Jean Clifford at the PMI briefing.
Now is the chance for healthcare professionals to see this AI in action, whether they’re developing a new AI implementation strategy or looking to improve programs that they’ve already launched https://t.co/B5zegePIKw
The AIHD Conference will be an opportunity to meet the AI trail-blazers, learn from their real-world experiences, and find best practices for AI development and implementation to improve business operations and patient care. https://t.co/B5zegf7k96
Join Talking Laboratories and the Dark Intelligence Precision Medicine LIVE Briefing on Jan 4, 2022, for a discussion of Pharmacogenomics Laboratory Stewardship. Register at https://t.co/ZlsTyHWI1a
Happy New Year from Talking Laboratories. Check out our two blog series from 2021 focusing on auto-verification. Get inspired and reap the benefits of rules logic. Go to https://t.co/JzwI9iTPzb and get ready for 2022.
Join Talking Laboratories & the Precision Medicine Institute™ for Briefing Episode 9. Emily Johnson, JD and Courtney Tito, JD at McDonald Hopkins, will discuss new FDA & LDT considerations and clinical utility of data and reimbursement.
Register Now | https://t.co/swQbX4MEg0
Join Talking Labs and the Precision Medicine Institute for episode 7 featuring Dr. Pranil Chandra, VP and Chief Medical Officer of Pathgroup and an advisor to the PMI. He will discuss the reasons for growth in precision oncology testing.